However, it is important to note that, as previously discussed by [10], the phenotype related to the VWF deletion is well defined by clinical symptoms and laboratory parameters and corresponds to type 3 VWD, whereas at present a phenotype associated to the TMEM16B deletion has not been identified. Here, ANO2 is linked to von Willebrand disease 3.